CSL (CSJ) Stock Forecast & Price Target

2 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

CSJ Analyst Ratings

Moderate Buy

3 Buy

8 Hold

0 Sell

Based on 11 analysts giving stock ratings to

CSL

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

CSJ Stock 12 Month Forecast

Average Price Target

€80.64

▲(14.18% Upside)

Based on 11 Wall Street analysts offering 12 month price targets for CSL in the last 3 months. The average price target is €80.64 with a high forecast of €116.51 and a low forecast of €64.85. The average price target represents a 14.18% change from the last price of €70.63.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"57":"€57","146":"€146","79.25":"€79.3","101.5":"€101.5","123.75":"€123.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":116.512865,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€116.51</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":80.64398299999999,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€80.64</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":64.85069465,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€64.85</span>\n  </div></div>","useHTML":true}}],"tickPositions":[57,79.25,101.5,123.75,146],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,72.18,75.59022038461539,79.00044076923078,82.41066115384616,85.82088153846155,89.23110192307693,92.64132230769232,96.05154269230769,99.46176307692309,102.87198346153846,106.28220384615386,109.69242423076923,113.10264461538462,{"y":116.512865,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,72.18,72.83107561538462,73.48215123076923,74.13322684615385,74.78430246153846,75.43537807692307,76.08645369230769,76.73752930769231,77.38860492307693,78.03968053846154,78.69075615384615,79.34183176923077,79.99290738461538,{"y":80.64398299999999,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,72.18,71.61620728076923,71.05241456153847,70.4886218423077,69.92482912307693,69.36103640384616,68.79724368461538,68.23345096538462,67.66965824615384,67.10586552692307,66.5420728076923,65.97828008846153,65.41448736923077,{"y":64.85069465,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":127.803,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":145.409,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":114.843,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":110.182,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":98.631,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":101.217,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":96.933,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":102.58,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":88.462,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":84.28,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":76.32,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":58.55,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":72.18,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€116.51

Average Price Target€80.64

Lowest Price Target€64.85

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

David Low

UBS

€96.38

Buy

36.46%

Upside

Reiterated

07/31/26

UBS Sticks to Its Buy Rating for CSL (CMXHF)

Thomas Wakim

Bell Potter

€61→€73.2

Hold

3.64%

Upside

Reiterated

07/31/26

Bell Potter Sticks to Their Hold Rating for CSL (CMXHF)

Laura Sutcliffe

Citi

€67.1

Hold

-5.00%

Downside

Reiterated

07/29/26

Analysts Conflicted on These Healthcare Names: CSL (Other OTC: CMXHF), Oneview Healthcare Chess Depository Interests repr 1 (Other OTC: ONVVF) and Polynovo (Other OTC: CALZF)

Christine Trinh

Macquarie

€69.54→€65.88

Hold

-6.72%

Downside

Reiterated

07/29/26

Analysts Offer Insights on Healthcare Companies: CSL (Other OTC: CMXHF) and Alkermes (NASDAQ: ALKS)

David Stanton

Jefferies

€65.88→€72.59

Hold

2.78%

Upside

Reiterated

07/28/26

CSL (CMXHF) Gets a Hold from Jefferies

Unknown Analyst

Ord Minnett

Not Ranked

Ord Minnett

€71.37→€75.21

Hold

6.49%

Upside

Reiterated

07/23/26

Ord Minnett Reaffirms Their Hold Rating on CSL (CMXHF)

David Bailey

Morgan Stanley

€106.14→€99.43

Buy

40.78%

Upside

Reiterated

07/21/26

Analysts Offer Insights on Healthcare Companies: CSL (Other OTC: CMXHF), Danaher (NYSE: DHR) and TransMedics Group (NASDAQ: TMDX)

Craig Wong-Pan

RBC Capital

€65.27→€65.88

Hold

-6.72%

Downside

Reiterated

07/16/26

RBC Capital Sticks to Their Hold Rating for CSL (CMXHF)

Steven Wheen

Jarden

€148.84→€116.51

Hold

64.96%

Upside

Downgraded

05/12/26

Jarden downgrades CSL (CMXHF) to a Hold

Shane Storey

Canaccord Genuity

€109.8→€64.85

Hold

-8.18%

Downside

Downgraded

05/12/26

Canaccord Genuity downgrades CSL (CMXHF) to a Hold

Derek Jellinek

Morgans

€147.22→€90.03

Buy

27.47%

Upside

Reiterated

05/12/26

CSL (CMXHF) Receives a Buy from Morgans

Davinthra Thillainathan

Goldman Sachs

€189.71→€129.38

Buy

83.19%

Upside

Reiterated

10/29/25

Goldman Sachs Reaffirms Their Buy Rating on CSL (CMXHF)

Andrew Paine

CLSA

€192.15→€167.75

Buy

137.51%

Upside

Reiterated

10/13/25

CLSA Keeps Their Buy Rating on CSL (CMXHF)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

David Low

UBS

€96.38

Buy

36.46%

Upside

Reiterated

07/31/26

UBS Sticks to Its Buy Rating for CSL (CMXHF)

Thomas Wakim

Bell Potter

€61→€73.2

Hold

3.64%

Upside

Reiterated

07/31/26

Bell Potter Sticks to Their Hold Rating for CSL (CMXHF)

Laura Sutcliffe

Citi

€67.1

Hold

-5.00%

Downside

Reiterated

07/29/26

Analysts Conflicted on These Healthcare Names: CSL (Other OTC: CMXHF), Oneview Healthcare Chess Depository Interests repr 1 (Other OTC: ONVVF) and Polynovo (Other OTC: CALZF)

Christine Trinh

Macquarie

€69.54→€65.88

Hold

-6.72%

Downside

Reiterated

07/29/26

Analysts Offer Insights on Healthcare Companies: CSL (Other OTC: CMXHF) and Alkermes (NASDAQ: ALKS)

David Stanton

Jefferies

€65.88→€72.59

Hold

2.78%

Upside

Reiterated

07/28/26

CSL (CMXHF) Gets a Hold from Jefferies

Unknown Analyst

Ord Minnett

Not Ranked

Ord Minnett

€71.37→€75.21

Hold

6.49%

Upside

Reiterated

07/23/26

Ord Minnett Reaffirms Their Hold Rating on CSL (CMXHF)

David Bailey

Morgan Stanley

€106.14→€99.43

Buy

40.78%

Upside

Reiterated

07/21/26

Analysts Offer Insights on Healthcare Companies: CSL (Other OTC: CMXHF), Danaher (NYSE: DHR) and TransMedics Group (NASDAQ: TMDX)

Craig Wong-Pan

RBC Capital

€65.27→€65.88

Hold

-6.72%

Downside

Reiterated

07/16/26

RBC Capital Sticks to Their Hold Rating for CSL (CMXHF)

Steven Wheen

Jarden

€148.84→€116.51

Hold

64.96%

Upside

Downgraded

05/12/26

Jarden downgrades CSL (CMXHF) to a Hold

Shane Storey

Canaccord Genuity

€109.8→€64.85

Hold

-8.18%

Downside

Downgraded

05/12/26

Canaccord Genuity downgrades CSL (CMXHF) to a Hold

Derek Jellinek

Morgans

€147.22→€90.03

Buy

27.47%

Upside

Reiterated

05/12/26

CSL (CMXHF) Receives a Buy from Morgans

Davinthra Thillainathan

Goldman Sachs

€189.71→€129.38

Buy

83.19%

Upside

Reiterated

10/29/25

Goldman Sachs Reaffirms Their Buy Rating on CSL (CMXHF)

Andrew Paine

CLSA

€192.15→€167.75

Buy

137.51%

Upside

Reiterated

10/13/25

CLSA Keeps Their Buy Rating on CSL (CMXHF)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

AVBPArriVent BioPharma, Inc.

BTSGBrightSpring Health Services, Inc.

MLYSMineralys Therapeutics, Inc.

AMLXAmylyx Pharmaceuticals Inc

ZURAZura Bio

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering CSL

3 Months

David BaileyMorgan Stanley

Success Rate

10/22 ratings generated profit

Average Return

-2.83%

Copying David Bailey's trades and holding each position for 3 Months would result in 45.45% of your transactions generating a profit, with an average return of -2.83% per trade.

1 Year

Andrew PaineCLSA

Success Rate

8/23 ratings generated profit

Average Return

-5.82%

Copying Andrew Paine's trades and holding each position for 1 Year would result in 34.78% of your transactions generating a profit, with an average return of -5.82% per trade.

2 Years

Andrew PaineCLSA

Success Rate

5/23 ratings generated profit

Average Return

-14.57%

Copying Andrew Paine's trades and holding each position for 2 Years would result in 21.74% of your transactions generating a profit, with an average return of -14.57% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CSJ Analyst Recommendation Trends

Rating

Mar 26

Apr 26

May 26

Jun 26

Jul 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, CSJ has received 13 Buy Ratings, 23 Hold Ratings, and 0 Sell Ratings. CSJ average Analyst price target in the past 3 months is 80.64.

Each month's total comprises the sum of three months' worth of ratings.

CSJ Financial Forecast

CSJ Earnings Forecast

Next quarter’s earnings estimate for CSJ is €2.04 with a range of €2.02 to €2.07. The previous quarter’s EPS was €3.49. CSJ beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 45.99% of the time in the same period. In the last calendar year CSJ has Performed in-line its overall industry.

CSJ Sales Forecast

Next quarter’s sales forecast for CSJ is €6.16B with a range of €5.87B to €6.33B. The previous quarter’s sales results were €7.66B. CSJ beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 29.50% of the time in the same period. In the last calendar year CSJ has Performed in-line its overall industry.

CSJ Stock Forecast FAQ

What is DE:CSJ’s average 12-month price target, according to analysts?

Based on analyst ratings, CSL’s 12-month average price target is 80.64.

What is DE:CSJ’s upside potential, based on the analysts’ average price target?

CSL has 14.18% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is CSL a Buy, Sell or Hold?

CSL has a consensus rating of Moderate Buy, which is based on 3 buy ratings, 8 hold ratings and 0 sell ratings.

What is CSL’s share price target?

The average share price target for CSL is 80.64. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €116.51 ,and the lowest forecast is €64.85. The average share price target represents 14.18% Increase from the current price of €70.63.

What do analysts say about CSL?

CSL’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 11 Wall Streets Analysts.

How can I buy shares of CSL?

To buy shares of DE:CSJ, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

CSL (CSJ) Stock Forecast & Price Target

CSJ Analyst Ratings

CSJ Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering CSL

CSJ Analyst Recommendation Trends

CSJ Financial Forecast

CSJ Earnings Forecast

CSJ Sales Forecast

CSJ Stock Forecast FAQ

Detailed List of Analyst Forecasts